Halper Sadeh LLC is investigating whether the sale transactions of Sila Realty Trust and Lisata Therapeutics provide fair value to their shareholders. The law firm alleges insiders may receive financial benefits not available to ordinary shareholders and that deal terms might restrict better competing offers. Sila is being sold to Blue Owl Real Estate Capital for $30.38 per share, while Lisata is being acquired by Kuva Labs for $4.00 per share plus contingent value rights. Shareholders are encouraged to explore their legal options, as the firm may seek increased compensation or additional disclosures on their behalf.
Silvaco and NVIDIA have teamed up to enhance semiconductor design and manufacturing by integrating NVIDIA's AI and accelerated computing with Silvaco's physics-based simulation technology. This collaboration aims to create high-fidelity digital twins...
Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, was ranked No. 3 on The Medicine Maker Power List 2026 in the Small Molecules category, recognizing his leadership in oncology drug development. Under his guidance, Ascentage Pharma has advanced i...
Chipotle Mexican Grill launched its first restaurant in Mexico on July 16 in San Pedro Garza García, Nuevo León, partnering with Alsea. This marks the beginning of Chipotle's international growth strategy in Mexico, with plans to open more locations ...
AI investment is rapidly increasing, with hyperscaler spending expected to grow from $673 billion in 2024 to $892 billion by 2028. Despite strong revenue growth from companies like Alphabet, concerns about overinvestment have caused significant marke...
Robert Half is rated a hold after Q1 due to improving staffing trends but continued weakness in Permanent Placement and pressure on Protiviti's revenue and margins. The decline in Protiviti is linked to less regulatory remediation work, only partly o...
